Brian Dennehy News
-
See what’s happening among “The Ungovernables,” about 50 young artists who are part of the New Museum’s 2012 Triennial, many of whom have never been shown in this city.
-
The early end of James Marshall ’s career, blamed by the actor and musician on Roche Holding AG ’s Accutane acne drug, was an “unbelievable tragedy,” former co- star Brian Dennehy said in court.
-
Roche Holding AG faces a lineup of Hollywood stars in the New Jersey trial of an actor’s lawsuit alleging he suffered the loss of his colon after taking the company’s Accutane acne drug.
-
Ex-McKinsey & Co. director Anil Kumar told a jury that Galleon Group LLC co-founder Raj Rajaratnam secretly hired him as a consultant in 2003 for $500,000 to be paid into a Swiss bank account, in violation of McKinsey rules.
-
Nancy Kissel, accused of murdering her banker husband, broke down in a Hong Kong court today after saying that she wasn’t able to help their daughter and said she tried to protect herself from abuse by spiking his drinks.
-
Martin Sheen described the “extraordinary” talent of fellow actor James Marshall in a trial claiming Roche Holding AG ’s Accutane acne drug caused Marshall’s inflammatory bowel disease.
-
You have 58 chances left to catch “Jesus Christ Superstar” at Canada’s Stratford Festival and decide for yourself whether Des McAnuff’s chilling revival deserves the hoopla that has made it the summer’s most talked- about show.
-
Jon Huntsman Jr., the former Utah governor and Obama administration envoy to China, formally announced his presidential bid today, positioning himself as an unconventional fresh face in a crowded Republican field.
-
“ The Next Three Days ,” starring Russell Crowe as a college professor who tries to break his wife out of prison, is a smart, suspenseful thriller that slowly comes together like a jigsaw puzzle.
-
Samuel Wyly and Charles Wyly, the Texan brothers and entrepreneurs who funded ads helping George W. Bush’s presidential campaigns, were sued by U.S. regulators who accused them of misleading investors while selling hundreds of millions of dollars in stock.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page